Dose Reduction or Treatment Interruption Pro: Treatment Interruption and individualized dose/schedule alterationIndividualized Sunitinib as an example?

Dr. Georg A. BjarnasonDivision of Medical OncologySunnybrook Odette Cancer CentreAssociate Professor, Faculty ofÂ Medicine, University of Toronto discusses Dose Reduction or Treatment Interruption Pro: Treatment Interruption and individualized dose/schedule alterationIndividualized Sunitinib as an example? at the Kidney Cancer meeting in Chicago

Advertisement Single Below Content

Dose Reduction or Treatment Interruption Pro: Treatment Interruption and individualized dose/schedule alterationIndividualized Sunitinib as an example?

Advancing Acute Lymphoblastic Leukemia Treatment with CAR-T Cells: Insights from Dr. Anjali Advani

Advances in Acute Lymphoblastic Leukemia (ALL) Treatment: A Focus on Targeted Therapies – Elias Jabbour, MD

FDA grants accelerated approval to ponatinib (ICLUSIG®) with chemotherapy for newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia

Dose Reduction or Treatment Interruption Pro: Treatment Interruption and individualized dose/schedule alteration Individualized Sunitinib as an example?

Related Posts

Advancing Acute Lymphoblastic Leukemia Treatment with CAR-T Cells: Insights from Dr. Anjali Advani

Advances in Acute Lymphoblastic Leukemia (ALL) Treatment: A Focus on Targeted Therapies – Elias Jabbour, MD

FDA grants accelerated approval to ponatinib (ICLUSIG®) with chemotherapy for newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia

Dose Reduction or Treatment Interruption Pro: Treatment Interruption and individualized dose/schedule alterationIndividualized Sunitinib as an example?